SCHEMBL2838307

SCHEMBL2838307

CCN1Cc2sccc2C(Oc2ccc(Cl)c(Cl)c2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
SLC6A4 P31645 4/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A3 Q01959 3/20 0.36
KCNH2 Q12809 4/20 0.34
CYP2D6 P10635 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
HRH1 P35367 2/20 0.33
CCR2 P41597 1/20 0.32
CCR3 P51677 1/20 0.32
HPGD P15428 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN5 P54829 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2837155 0.99 KDM4E (0.37) KDM4ESLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL2840801 0.88 OPRD1 (0.39) KDM4ESLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL2843946 0.84 NPC1 (0.42) KDM4ESLC6A4SLC6A2SLC6A3KCNH2
Hydrochloric Acid SCHEMBL2841695 0.83 SLC6A4 (0.34) KDM4ESLC6A4SLC6A2SLC6A3KCNH2
Hydrochloric Acid SCHEMBL2845465 0.77 SLC6A2 (0.40) KDM4ESLC6A4SLC6A2SLC6A3ALDH1A1
SCHEMBL2836992 0.77 KDM4E (0.38) KDM4ESLC6A4SLC6A2SLC6A3KCNH2
Hydrochloric Acid SCHEMBL2837012 0.77 ALDH1A1 (0.38) KDM4ESLC6A4SLC6A2SLC6A3ALDH1A1
Hydrochloric Acid SCHEMBL2840931 0.76 OPRD1 (0.38) KDM4ESLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL2841690 0.76 OPRD1 (0.40) KDM4ESLC6A4SLC6A2SLC6A3ALDH1A1
SCHEMBL2838043 0.74 SLC6A2 (0.35) KDM4ESLC6A4SLC6A2SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US claimed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP claimed
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 KDM4E 3292/4885SLC6A4 185/4885SLC6A2 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.